Bifogade filer
PDF
Kurs
-5,86%
Likviditet
2,68 MNOK
Kalender
| Tid* | ||
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-22 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-26 | - | Årsstämma |
| 2024-06-06 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-01 | - | Bokslutskommuniké 2023 |
| 2023-11-02 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-07 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2023-06-06 | - | Årsstämma |
| 2023-05-04 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-02 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-23 | - | Årsstämma |
| 2022-05-27 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-01-27 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-19 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-21 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2021-05-20 | - | Årsstämma |
| 2021-04-22 | - | Kvartalsrapport 2021-Q1 |
| 2021-01-28 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-19 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-15 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2020-05-14 | - | Årsstämma |
| 2020-04-23 | - | Kvartalsrapport 2020-Q1 |
| 2020-01-30 | - | Bokslutskommuniké 2019 |
| 2020-01-06 | - | Extra Bolagsstämma 2020 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-15 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-16 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2019-05-15 | - | Årsstämma |
| 2019-04-30 | - | Kvartalsrapport 2019-Q1 |
| 2019-01-30 | - | Bokslutskommuniké 2018 |
| 2018-10-18 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-09 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2018-05-07 | - | Årsstämma |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-01 | - | Bokslutskommuniké 2017 |
| 2017-10-19 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-17 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-12 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2017-05-11 | - | Årsstämma |
| 2017-04-27 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-02 | - | Bokslutskommuniké 2016 |
| 2016-10-26 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-12 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2016-05-11 | - | Årsstämma |
| 2016-04-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-11 | - | Kapitalmarknadsdag 2016 |
| 2016-02-11 | - | Bokslutskommuniké 2015 |
| 2015-11-03 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-13 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-13 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2015-05-12 | - | Årsstämma |
| 2015-05-05 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-17 | - | Bokslutskommuniké 2014 |
| 2014-11-05 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-13 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-15 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2014-05-14 | - | Årsstämma |
| 2014-04-30 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-14 | - | Bokslutskommuniké 2013 |
| 2013-11-01 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-09 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-13 | - | Kapitalmarknadsdag 2013 |
| 2013-05-28 | - | X-dag ordinarie utdelning |
| 2013-05-27 | - | Årsstämma |
| 2013-05-07 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-01 | - | Extra Bolagsstämma 2013 |
| 2013-01-07 | - | Bokslutskommuniké 2012 |
| 2012-11-06 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-10 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-07 | - | Årsstämma |
| 2012-05-07 | - | Kvartalsrapport 2012-Q1 |
| 2012-05-07 | - | X-dag ordinarie utdelning AZT 0.00 NOK |
| 2012-02-21 | - | Bokslutskommuniké 2011 |
| 2011-11-08 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-10 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-13 | - | Årsstämma |
| 2011-05-13 | - | Kvartalsrapport 2011-Q1 |
| 2011-05-12 | - | X-dag ordinarie utdelning |
| 2011-02-17 | - | Bokslutskommuniké 2010 |
| 2010-11-12 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-10 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-11 | - | Kvartalsrapport 2010-Q1 |
| 2010-05-04 | - | Årsstämma |
| 2010-03-03 | - | Bokslutskommuniké 2009 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Tromsø, Norway, May 13[th], 2024 - ArcticZymes Technologies (OSE: AZT) announces Nominations for new Board members and the resignation of the Chairman and a Board member.
ArcticZymes today announces changes to its governance structure. The Election committee has proposed changes to the Board to guide and strengthen the strategic and commercial development of the company.
Nomination of New Board Members
ArcticZymes is pleased to introduce three distinguished individuals nominated to join its Board of directors. These nominees bring expertise and experience in the biomanufacturing and financial sectors, enriching ArcticZymes' strategic direction, commercialization efforts, and governance practices:Mrs. Sharon Brownlow: With a background in Biotech and extensive experience in the cell and gene therapy industry, Mrs. Brownlow is renowned for blending her scientific roots with entrepreneurial drive. Her proven track record includes senior commercial roles in Catapult and Cobra Biologics, where she effectively drove strategic business momentum and long-term revenue growth.
Mr. Petter Dragesund: Former Senior Partner at Pareto Securities, Mr. Dragesund boasts nearly three decades of experience in investment banking. Serving in various capacities at Pareto from 1992 to 2021, including Head of the Corporate Finance department from 2001 to 2014, he brings invaluable financial acumen to the Board. Since 2021, Mr. Dragesund has been an independent investor, further broadening his insights into market dynamics.
A third Board member, currently a Life Science Executive, will be nominated shortly. With a remarkable track record in scaling public life science companies and devising successful growth strategies, this individual possesses deep insights into the challenges and opportunities within drug development and commercialization broadly.
Resignation of Chairman and Board Member
Mrs. Marie Roskrow, Chairman of the Board, has resigned, effective immediately. During her six-year tenure, Mrs. Roskrow played a pivotal role in elevating ArcticZymes into a globally profitable player in the life science tools sector. Her leadership laid a robust foundation for long-term growth, for which the Election committee extends its sincere appreciation.
Board member Mrs. Jane Theaker has also resigned, citing personal reasons. The committee acknowledges Mrs. Theaker's valuable contributions and thanks her for her service.
New date of the Annual General Meeting (AGM) is June 26[th], 2024
For practical reasons ArcticZymes has decided to move its Annual General Meeting (AGM), originally scheduled for June 5[th], to June 26[th], 2024. The financial calendar will be updated as well.
-Ends-
For more information, please contact:
ArcticZymes Technologies ASA
CEO, MIchael B. Akoh Tel: +46 (0) 70 262 37 15
CFO, Børge Sørvoll Tel: +47 952 90 187
ir@arcticzymes.com
About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.
Listed on the Oslo Stock Exchange since 2005 originally under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA Innovation Centre.
ArcticZymes Technologies' IP and capabilities are protected via a large portfolio of patents.
For more information, please visit the website: www.arcticzymes.com